• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      United States $240+ Billion Digital Health Markets to 2026 - Upsurge in the Number of Healthcare Apps & Escalating Penetration of Electronic Health Record (EHR) Systems - 3 year(s) ago

      Dublin, April 21, 2022 (GLOBE NEWSWIRE) — The “US Digital Health Market (by Technology & Component): Insights & Forecast with Potential Impact…

      Source: GlobeNewswire News Room
      Categories: Future of Medicine, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	TWDigitalHealth
        TWDigitalHealth

        United States $240+ Billion #DigitalHealth Markets to 2026 - Upsurge in the Number of Healthcare Apps & Escalating Penetration of Electronic Health Record (EHR) Systems https://t.co/I4HoYqD75B https://t.co/apUEjAif67

    • Mashup Score: 0
      Worldwide Telehealth Industry to 2027 - Featuring Biotelemetry, Cisco Systems and GE Healthcare Among Others - 3 year(s) ago

      Dublin, April 21, 2022 (GLOBE NEWSWIRE) — The “Telehealth Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027″…

      Source: GlobeNewswire News Room
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	RttCraig
        RttCraig

        Worldwide Telehealth Industry to 2027 - Featuring Biotelemetry, Cisco Systems and GE Healthcare Among Others https://t.co/gihFyUL7lf #connectedhealth #globalpublichealth #telemedicine #telehealth #technology #healthcare #artificialintelligence #digitalhealth #behavioralhealth

    • Mashup Score: 0
      Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy - 3 year(s) ago

      — Independent Data Monitoring Committee Unanimously Recommends that Phase 3 Clinical Trial for Sabizabulin for Treatment of Hospitalized COVID-19 Patients…

      Source: GlobeNewswire News Room
      Categories: Hem/Oncs, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	nickmmark
        nickmmark

        Per the press release (ugh): Trial stopped early by IDMC after n=150 enrolled due to efficacy: Mortality was 20% in treatment group (n=98) vs 45% in placebo group (n=52). This is a big difference, though stopping early may overestimate effect size. https://t.co/ZdOuZu7svm 7/ https://t.co/iW0VasQ19s

    • Mashup Score: 0
      Global E prescription Market 2022 | Stunning Growth at CAGR of 22.5%, to reach a value of USD 5,346.62 Million by 2028 | Industry Demand, Trend, Dynamics by Vantage Market Research - 3 year(s) ago

      WASHINGTON, April 04, 2022 (GLOBE NEWSWIRE) — Vantage Market Research published a report, titled, “E prescription Market Size, Share & Trends…

      Source: GlobeNewswire News Room
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	RttCraig
        RttCraig

        Global E prescription Market 2022 | Stunning Growth at CAGR of 22.5%, to reach a value of USD 5,346.62 Million by 2028 | Industry Demand, Trend, Dynamics by Vantage Market Research https://t.co/TncQx9WN4f #telemedicine #telehealth #technology #healthcare #artificialintelligence

    • Mashup Score: 1
      UniDoc Signs MOU to Provide Telehealth Services in Ghana - 3 year(s) ago

      West African deployment targets initial potential for 2 million patients…

      Source: GlobeNewswire News Room
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	RttCraig
        RttCraig

        UniDoc Signs MOU to Provide Telehealth Services in Ghana https://t.co/PBvFXGhMBH #telemedicine #telehealth #technology #healthcare #artificialintelligence #digitalhealth #behavioralhealth #mentalhealth #connectedhealth #globalpublichealth

    • Mashup Score: 6
      Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer - 3 year(s) ago

      Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68…

      Source: GlobeNewswire News Room
      Categories: Latest Headlines, Oncologists2
      Tweet Tweets with this article
      • Profile photo of 	dralvaropinto
        dralvaropinto

        Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer https://t.co/ImLSiM22W8

    • Mashup Score: 0
      Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results - 3 year(s) ago

      Significant Progress Anticipated in 2022 with Initiation of Clinical Trial for VERVE-101 and IND-enabling Studies for ANGPTL3 Program Presentations at…

      Source: GlobeNewswire News Room
      Categories: Cardiologists, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	skathire
        skathire

        Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results https://t.co/hyrGNqz6uS

    • Mashup Score: 0
      Telehealth Virtual Visits Market 2022 Business Overview, Global Size, Industry Dynamics, Key Opportunities, Mergers & Acquisitions, Expansion Plans, Top Trends, Recent Development, Leading Company and Forecast to 2027 | Industry Research - 3 year(s) ago

      Pune, March 08, 2022 (GLOBE NEWSWIRE) — “Final report will add the analysis of the Impact of Covid-19 in this Telehealth Virtual Visits Market.” Global…

      Source: GlobeNewswire News Room
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	RttCraig
        RttCraig

        Telehealth Virtual Visits Market 2022 Business Overview, Global Size, Industry Dynamics, Key Opportunities, Mergers & Acquisitions, Expansion Plans, Top Trends, Recent Development, Leading Company and Forecast to 2027 | Industry Research https://t.co/XSofhfOhOe #telemedicine

    • Mashup Score: 0
      Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems - 3 year(s) ago

      Announces integrations with multiple leading Electronic Health Record (EHR) systemsIntroduces a new solution to enable Remote Therapeutic Monitoring (RTM)…

      Source: GlobeNewswire News Room
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	wheezemd
        wheezemd

        Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems https://t.co/Fyd3s3c8gn

    • Mashup Score: 0
      Intellia and Regeneron Announce Updated Phase 1 Data Demonstrating a Single Dose of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis, Resulted in Rapid, Deep and Sustained Reduction in Disease-Causing Protein - 3 year(s) ago

      Achieved 86% and 93% mean serum TTR reduction by day 28 at 0.7 mg/kg and 1.0 mg/kg doses, respectively, with dose-dependent reductions observed across all…

      Source: GlobeNewswire News Room
      Categories: Cardiologists, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	chaz_hong
        chaz_hong

        Is ATTR-CM (hereditary cardiac amyloidosis) next? @wang_libin @UM_Cardiology https://t.co/5HU3wU2YUa

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings